Teligent, Inc. - stock earnings

TLGT Quarterly earnings

DateEarningsRevenue
2021Q2 -12.9 million USD 10.4 million USD
2021Q1 2.2 million USD 11.6 million USD
2020Q4 -80.3 million USD 9.9 million USD
2020Q3 -510000 USD 14.3 million USD

TLGT Yearly earnings

DateEarningsRevenue
2020 -122.0 million USD 45.3 million USD
2019 -25.1 million USD 65.9 million USD
2018 -36.3 million USD 65.9 million USD
2017 -15.2 million USD 60.2 million USD

TLGT

Price: $0.17

52 week price:
0.02
1.60

Earnings Per Share: -0.39 USD

P/E Ratio: -0.05

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 72.2 million

Ebitda: -4.2 million

Market Capitalization: 16.1 million

Links: